News
Filters
Evidation appoints Phil Johnson as Chief Commercial Officer
Evidation appoints Phil Johnson as Chief Commercial Officer
Evidation appoints Phil Johnson as Chief Commercial Officer
Evidation appoints Phil Johnson as Chief Commercial Officer
Evidation announces the addition of a new Chief Commercial Officer, Phil Johnson, and board member, Ian Lennox.
Evidation launches MigraineSmart on the Evidation app
Evidation launches MigraineSmart on the Evidation app
Evidation launches MigraineSmart on the Evidation app
Evidation launches MigraineSmart on the Evidation app
Evidation has officially launched MigraineSmart, a health engagement experience and symptom tracking program on the Evidation app that harnesses different forms of data to help individuals better understand and manage their migraines.
Trialbee and Evidation partner to accelerate and diversify clinical research recruitment
Trialbee and Evidation partner to accelerate and diversify clinical research recruitment
Trialbee and Evidation partner to accelerate and diversify clinical research recruitment
Trialbee and Evidation partner to accelerate and diversify clinical research recruitment
Learn how Evidation and Trialbee's joint offering and shared commitment to inclusion and data transparency drives enrollment outcomes.
Rock Health shares findings from weight care survey with Evidation
Rock Health shares findings from weight care survey with Evidation
Rock Health shares findings from weight care survey with Evidation
Rock Health shares findings from weight care survey with Evidation
Evidation helped Rock Health conduct surveys that investigated experience and perceptions of a variety of weight care solutions. Read key highlights here.
Frost & Sullivan awards Evidation for its direct-to-participant real world data solutions
Frost & Sullivan awards Evidation for its direct-to-participant real world data solutions
Frost & Sullivan awards Evidation for its direct-to-participant real world data solutions
Frost & Sullivan awards Evidation for its direct-to-participant real world data solutions
Evidation’s consumer app and research platform have been recognized by Frost & Sullivan for the value they provide to life science and healthcare organizations and individuals in everyday life
Evidation shares real world data on GLP-1 use and social determinants of health at ISPOR 2024
Evidation shares real world data on GLP-1 use and social determinants of health at ISPOR 2024
Evidation shares real world data on GLP-1 use and social determinants of health at ISPOR 2024
Evidation shares real world data on GLP-1 use and social determinants of health at ISPOR 2024
Evidation will be presenting recent research findings in two accepted abstracts at this year’s International Society for Pharmacoeconomics and Outcomes Research (ISPOR) conference in Atlanta.
Evidation selected by Our Future Health as participant platform for UK’s largest health research program
Evidation selected by Our Future Health as participant platform for UK’s largest health research program
Evidation selected by Our Future Health as participant platform for UK’s largest health research program
Evidation selected by Our Future Health as participant platform for UK’s largest health research program
Evidation’s digital health engagement and measurement platform has been selected by Our Future Health to power the multi-year, longitudinal research program for up to five million participants across the UK.
BARDA expands partnership with Evidation to validate and improve machine learning models for early detection of influenza-like illness using wearables
BARDA expands partnership with Evidation to validate and improve machine learning models for early detection of influenza-like illness using wearables
BARDA expands partnership with Evidation to validate and improve machine learning models for early detection of influenza-like illness using wearables
BARDA expands partnership with Evidation to validate and improve machine learning models for early detection of influenza-like illness using wearables
Evidation announced that BARDA has awarded the company a contract to fund the 2023 Influenza-like Illness (ILI) Detect & Protect Studies.
Evidation partners with USC on the Understanding America Study to characterize healthy aging using wearables and real-world data
Evidation partners with USC on the Understanding America Study to characterize healthy aging using wearables and real-world data
Evidation partners with USC on the Understanding America Study to characterize healthy aging using wearables and real-world data
Evidation partners with USC on the Understanding America Study to characterize healthy aging using wearables and real-world data
Evidation announced a partnership with USC’s Dornsife Center for Economic and Social Research to incorporate wearable device data into the landmark Understanding America Study.
Myovant Sciences and Evidation announce survey results of unseen burdens at work and school of individuals with endometriosis and/or uterine fibroids
Myovant Sciences and Evidation announce survey results of unseen burdens at work and school of individuals with endometriosis and/or uterine fibroids
Myovant Sciences and Evidation announce survey results of unseen burdens at work and school of individuals with endometriosis and/or uterine fibroids
Myovant Sciences and Evidation announce survey results of unseen burdens at work and school of individuals with endometriosis and/or uterine fibroids
Evidation and Myovant uncover staggering findings around the impact of endometriosis and uterine fibroids on quality of life.
No results found. Try broadening your search for more results!